Blocking the Horizon-Amgen deal will be worse for pharma than for biotech, says Mizuho’s Jared Holz

May 19, 2023
Blocking the Horizon-Amgen deal will be worse for pharma than for biotech, says Mizuho’s Jared HolzBlocking the Horizon-Amgen deal will be worse for pharma than for biotech, says Mizuho’s Jared Holz
Share This

Jared Holz, Mizuho healthcare sector strategist, joins ‘Fast Money’ to discuss merger and acquisition crackdowns in the biotech space, government regulation in the space, and more.

Latest Mizuho News

The Energy Department's '$17 billion question' around nuclear energy

The Energy Department's '$17 billion question' around nuclear energy

June 29, 2026
Robinhood could be first ‘hyperscaler’ of online brokerages, says Mizuho’s Dan Dolev

Robinhood could be first ‘hyperscaler’ of online brokerages, says Mizuho’s Dan Dolev

July 2, 2026
Why SpaceX's future depends on Starship

Why SpaceX's future depends on Starship

July 20, 2026

Mizuho news from around the globe

back-to-top-blue